DKSH has agreed to acquire Biomedic, a leading Vietnamese distributor in the biotechnology and diagnostics market, aiming to strengthen its position in the growing healthcare sector.

Target Information

DKSH has signed an agreement to acquire Biomedic Science Material Joint Stock Company ("Biomedic"), a prominent distributor of equipment and reagents in the biotechnology and diagnostic sectors in Vietnam. Founded in 2008 and headquartered in Hanoi, Biomedic boasts a workforce of over 80 employees spread across three locations in Vietnam, generating approximately CHF 12 million annually in net sales with healthy profitability. The company has successfully cultivated enduring relationships with renowned blue-chip clients, serving a diverse customer base that includes prestigious hospitals, testing centers, and fertility support facilities.

Biomedic operates on an equipment placement model, which enables it to earn a significant portion of its revenue from recurring consumables. According to Mr. Cao Tien Dung, the founder of Biomedic, this acquisition signifies a pivotal moment in their growth journey, offering potential growth opportunities for DKSH while allowing Biomedic to scale its operations through DKSH's strong sales channels.

Industry Overview in Vietnam

The biotechnology and diagnostic industries in Vietnam are rapidly evolving, driven by increasing healthcare needs, technological advancements, and a growing focus on personalized medicine. T